×
Suchbegriffe
Skip navigation
Über uns
Vorstand
Mitglieder
Mitgliedschaft
Statuten
Geschäftsstelle
Newsletter
Studies
Reviews
Swiss PH Registry
Prizes
Poster prize
Research Prize/Grant
Medical
Definition
Clinical classification
Functional classification
Screening and risk factors
Substrate recognition
Risk factors
Diagnosis
Clinical presentation
History
Chest X-Ray
Electrocardiogram (ECG)
Echocardiography
Lung function
Blood test and immunology
Scintigraphy
Computed tomography
Cardiac magnetic resonance imaging
Cardiopulmonary exercise testing (CPET)
Six-minute walk test
Hemodynamic assessment
References Diagnosis
Prognosis
SScl
CTEPH
Eisenmenger Syndrome
Altitude
Treatment
General measures
Supportive therapy
Specific drug therapy
Surgical treatments
Summary
Reimbursement and costs
Follow-up
Frequency of medical visits
Parameters for the follow-up
Pulmonary function test (PFT)
Exercise tests
Echocardiography
Right heart catheterization (RHC)
Biochemical markers
Risk stratification
Algorithms
Diagnostic workup
Algorithm for therapy
Algorithm high altitude pulmonary edema
High altitude PH
Classification
Risk Factors
Symptoms and Signs
Screening
ECG
Chest-X-Ray
CT
Right Heart Catheterization
Prognosis
Algorithm
References
Atrial septostomy
Ca-channel blockers and oral anticoagulation
Combination Therapy
CTEPH
Diagnosis of PPH
Echocardiography
Eisenmenger Syndrome
Emerging treatments
Endothelin receptor antagonists
General Measures
Hemodynamic Assessment
High altitude
HIV
Inotropic agents and calcium channel blockers in PAH
L-Arginine
Non-invasive ventilation
Portal Hypertension
Perspectives
Pregnancy
Prognosis
Prostanoids
Sildenafil
Thrombendarterectomy
Recommendations
Patienten
Lungenkreislauf
Pulmonale Hypertonie
Ursachen
Pulmonal Arterielle Hypertonie (PAH)
Pulmonale Venöse Hypertonie
Lungenkrankheiten oder Sauerstoffuntersättigung
Lungenembolien
Seltene Lungenkrankheiten
Klassifikation
Symptome
Diagnose
Blutbild
Blutgase
Röntgen
Echokardiogramm
Elektrokardiogramm (EKG)
Lungenfunktionstest
Lungenperfusionsszintigrafie
Pulmonalisangiografie
Pulmonaliskatheter
Therapie
Blutverdünnung
Bosentan
Beraprost
Diuretika
Iloprost
Kalziumantagonisten
Riociguat
Sildenafil
Thrombendarteriektomie
Transplantation
A bis Z
Tipps
FAQ
Literatur
Patientenorganisationen
Suisse romande
Deutschschweiz
Deutschland
Österreich
France
Links
Agenda
Kongresse / CME
Archiv
Fotogalerien
Partnerfirmen
Skip navigation
Home
Kontakt
Sitemap
Impressum
Skip navigation
Home
Kontakt
Sitemap
Impressum
Suchbegriffe
Skip navigation
Über uns
Vorstand
Mitglieder
Mitgliedschaft
Statuten
Geschäftsstelle
Newsletter
Studies
Reviews
Swiss PH Registry
Prizes
Poster prize
Research Prize/Grant
Medical
Definition
Clinical classification
Functional classification
Screening and risk factors
Substrate recognition
Risk factors
Diagnosis
Clinical presentation
History
Chest X-Ray
Electrocardiogram (ECG)
Echocardiography
Lung function
Blood test and immunology
Scintigraphy
Computed tomography
Cardiac magnetic resonance imaging
Cardiopulmonary exercise testing (CPET)
Six-minute walk test
Hemodynamic assessment
References Diagnosis
Prognosis
SScl
CTEPH
Eisenmenger Syndrome
Altitude
Treatment
General measures
Supportive therapy
Specific drug therapy
Surgical treatments
Summary
Reimbursement and costs
Follow-up
Frequency of medical visits
Parameters for the follow-up
Pulmonary function test (PFT)
Exercise tests
Echocardiography
Right heart catheterization (RHC)
Biochemical markers
Risk stratification
Algorithms
Diagnostic workup
Algorithm for therapy
Algorithm high altitude pulmonary edema
High altitude PH
Classification
Risk Factors
Symptoms and Signs
Screening
ECG
Chest-X-Ray
CT
Right Heart Catheterization
Prognosis
Algorithm
References
Atrial septostomy
Ca-channel blockers and oral anticoagulation
Combination Therapy
CTEPH
Diagnosis of PPH
Echocardiography
Eisenmenger Syndrome
Emerging treatments
Endothelin receptor antagonists
General Measures
Hemodynamic Assessment
High altitude
HIV
Inotropic agents and calcium channel blockers in PAH
L-Arginine
Non-invasive ventilation
Portal Hypertension
Perspectives
Pregnancy
Prognosis
Prostanoids
Sildenafil
Thrombendarterectomy
Recommendations
Patienten
Lungenkreislauf
Pulmonale Hypertonie
Ursachen
Pulmonal Arterielle Hypertonie (PAH)
Pulmonale Venöse Hypertonie
Lungenkrankheiten oder Sauerstoffuntersättigung
Lungenembolien
Seltene Lungenkrankheiten
Klassifikation
Symptome
Diagnose
Blutbild
Blutgase
Röntgen
Echokardiogramm
Elektrokardiogramm (EKG)
Lungenfunktionstest
Lungenperfusionsszintigrafie
Pulmonalisangiografie
Pulmonaliskatheter
Therapie
Blutverdünnung
Bosentan
Beraprost
Diuretika
Iloprost
Kalziumantagonisten
Riociguat
Sildenafil
Thrombendarteriektomie
Transplantation
A bis Z
Tipps
FAQ
Literatur
Patientenorganisationen
Suisse romande
Deutschschweiz
Deutschland
Österreich
France
Links
Agenda
Kongresse / CME
Archiv
Fotogalerien
Partnerfirmen
☰
Reviews
Summary on clinical trials in pulmonary hypertension
i. v. Epoprostenol
Other prostanoids
Bosentan and Sixtasentan
